This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2008 Oct 1;26(28):4537-8.

doi: 10.1200/JCO.2008.16.1398. Epub 2008 Jul 28.

Follicular lymphoma, survival, and rituximab: is it time to declare victory?

Sandra J Horning

PMID: 18662966
DOI: 10.1200/JCO.2008.16.1398

Editorial

Follicular lymphoma, survival, and rituximab: is it time to declare victory?

Sandra J Horning. J Clin Oncol. 2008.

. 2008 Oct 1;26(28):4537-8.

doi: 10.1200/JCO.2008.16.1398. Epub 2008 Jul 28.

Author

Sandra J Horning

PMID: 18662966
DOI: 10.1200/JCO.2008.16.1398

No abstract available

PubMed Disclaimer

Comment on

Phase III study of R-CVP compared with cyclophosphamide, vincristine, and prednisone alone in patients with previously untreated advanced follicular lymphoma.
Marcus R, Imrie K, Solal-Celigny P, Catalano JV, Dmoszynska A, Raposo JC, Offner FC, Gomez-Codina J, Belch A, Cunningham D, Wassner-Fritsch E, Stein G. Marcus R, et al. J Clin Oncol. 2008 Oct 1;26(28):4579-86. doi: 10.1200/JCO.2007.13.5376. Epub 2008 Jul 28. J Clin Oncol. 2008. PMID: 18662969 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.